John Maize, MD
Dermatopathology · Charleston, SCNPI 1043299787
Payments from drug & device makers
Across 578 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$1K
- Sanofi$1K
- Sun Pharmaceutical Industries Inc.$1K
- Regeneron Healthcare Solutions, Inc.$762
- Novartis$740
- plus $5K from 28 others
What the payments were for
- Food & beverage$10,62497%
- Education$3193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 85 | $1,384 |
| Johnson & Johnson | 64 | $1,274 |
| Sanofi | 42 | $1,073 |
| Sun Pharmaceutical Industries Inc. | 68 | $1,039 |
| Regeneron Healthcare Solutions, Inc. | 38 | $762 |
| Novartis | 33 | $740 |
| Incyte Corporation | 34 | $720 |
| Amgen | 29 | $659 |
| Pfizer | 33 | $543 |
| Lilly USA, LLC | 21 | $451 |
| UCB, Inc. | 21 | $382 |
| LEO Pharma Inc. | 17 | $351 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 22 | $317 |
| Galderma Laboratories, L.p. | 14 | $253 |
| Bristol Myers Squibb | 9 | $139 |
| Arcutis Biotherapeutics, Inc. | 4 | $111 |
| Mayne Pharma Commercial LLC | 7 | $107 |
| Organon | 5 | $100 |
| Almirall LLC | 4 | $98 |
| Genentech USA, Inc. | 5 | $82 |
| Biofrontera Inc. | 4 | $63 |
| Dermavant Sciences, Inc. | 3 | $58 |
| Sandoz | 2 | $33 |
| Myriad Genetic Laboratories, Inc. | 2 | $30 |
| Organogenesis Inc. | 1 | $25 |
| Therakos LLC | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Prugen, Inc. Pharmaceuticals | 3 | $19 |
| EPI Health, LLC | 1 | $18 |
| VYNE Pharmaceuticals Inc. | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
| Strata Skin Sciences, Inc. | 1 | $13 |
| Bioventus LLC | 1 | $12 |
| Aclaris Therapeutics, Inc. | 1 | $12 |
How this compares
Too few dermatopathology providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $87,484 |
| Fluorouracil | 21 | $941 |
| Clobetasol Propionate | 30 | $754 |
| Ketoconazole | 22 | $622 |
| Triamcinolone Acetonide | 40 | $330 |
| ValacyclovirValacyclovir Hcl | 16 | $263 |
| Minoxidil | 16 | $207 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Charleston
- Marta HamptonCharleston$26K
- John Sr MaizeCharleston$1K
- Courtney McFaddinGreenville$2K
- Robert JettonGreenville$498
- James PhillipsMt Pleasant$384
- Jing ZhangColumbia$188
- Scott MaischColumbia$66
- Alfonso GonzalezColumbia$25
- Miki LindseyColumbia$19
- Lawrence KleinColumbia$14
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.